drugset / Trial / NCT00728416

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)

NCT00728416

Phase 3 Completed 333 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study seeks to prospectively demonstrate that Nasonex is better than placebo in relieving nasal congestion in patients with seasonal allergic rhinitis.

Timeline

Start
2008-08
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 200 ug Other

Indications